Whereas Wnt-3a treatment induced an efficient translocation of β-catenin to the nucleus of the proliferative melanoma cells, TGFβ treatment also relocalized β-catenin to the nucleus, although to a lesser extent (Fig S3A and B). This evidence concerns the gene TGFB1 and melanoma.